Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zaratieg
    Member
    • Jun 2010
    • 19

    #1

    AT rich region depletion

    We are having some trouble with our ChIP-seqs: we seem to be completely blind to AT rich regions. When I check the GC distribution in the ChIP and Input reads I see that the input has maybe a 2% difference with the theoretical genomic reads, and in the IP reads the difference has increased to between 5 and 8%.

    We sonicate with a bioruptor, so I get that we won't ever get close to Covaris style temperature control. But what befuddles me is how the IP could have depleted AT rich sequences even more.

    Library prep was exactly the same for input and IP samples starting with cross-link reversal (65C o/n), then NEBnext library prep with only bead size selection, no gel purifications, and final amplification with 2x Phusion (NEB).

    Any advice will be appreciated. Also as an aside, how much of a GC% difference can current GC-normalization algorithms solve? How much is a complete write-off?
  • DJ Flowcell
    Member
    • Apr 2013
    • 13

    #2
    check out "Analyzing and minimizing PCR amplification bias
    in Illumina sequencing libraries" by Aird et. al. Phusion sucks for AT rich...there's a lot of tweaking that can be done in you amplification step to help get representation from extreme base composition sequences.

    Comment

    • zaratieg
      Member
      • Jun 2010
      • 19

      #3
      Thanks!! It's an interesting read. We'll try other Taqs.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Working...